600829.SS实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 15:00):

Stats
今日成交量	4.20M
平均成交量	6.60M
市值	3.74B
EPS	CNY0.150 ( 2023-09-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	12.40
ATR14	CNY0.00900 (0.14%)

音量相关性

長: -0.26 (neutral)

短: 0.53 (weak)

Signal:(57.403) Neutral

HPGC Renmintongtai 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

HPGC Renmintongtai 相关性 - 货币/商品

-0.20
( neutral )

-0.32
( neutral )

0.00
( neutral )

-0.45
( neutral )

HPGC Renmintongtai 财务报表

Annual	2023
营收:	CNY10.36B
毛利润:	CNY909.49M (8.78 %)
EPS:	CNY0.500

FY	2023
营收:	CNY10.36B
毛利润:	CNY909.49M (8.78 %)
EPS:	CNY0.500

FY	2022
营收:	CNY9.64B
毛利润:	CNY917.54M (9.52 %)
EPS:	CNY0.460

FY	2021
营收:	CNY9.32B
毛利润:	CNY995.13M (10.68 %)
EPS:	CNY0.480

Financial Reports:

No articles found.

HPGC Renmintongtai

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese medicines, Chinese herbal medicine, chemical preparations, antibiotics, biological products, and biochemical drugs, as well as medical equipment and health products. It also provides logistics services, including warehousing and distribution; and hospital services comprising medical treatment, scientific research, prevention, health care, rehabilitation, blood purification, and renal disease treatment. In addition, the company offers Chinese and Western medicines, Chinese herbal medicines, nourishing health care products, medical equipment, cosmetics, and daily necessities through an e-commerce platform. It operates 319 chain stores in Heilongjiang Province. The company was founded in 1950 and is headquartered in Harbin, China. HPGC Renmintongtai Pharmaceutical Corporation is a subsidiary of Harbin Pharmaceutical Group Co., Ltd.